NO20043018L - Streptococcus pneumoniae vaksine - Google Patents

Streptococcus pneumoniae vaksine

Info

Publication number
NO20043018L
NO20043018L NO20043018A NO20043018A NO20043018L NO 20043018 L NO20043018 L NO 20043018L NO 20043018 A NO20043018 A NO 20043018A NO 20043018 A NO20043018 A NO 20043018A NO 20043018 L NO20043018 L NO 20043018L
Authority
NO
Norway
Prior art keywords
streptococcus pneumoniae
pneumoniae vaccine
vaccine
streptococcus
pneumoniae
Prior art date
Application number
NO20043018A
Other languages
English (en)
Inventor
Jan Poolman
Craig Anthony Josep Laferriere
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of NO20043018L publication Critical patent/NO20043018L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20043018A 2001-12-18 2004-07-15 Streptococcus pneumoniae vaksine NO20043018L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0130215.7A GB0130215D0 (en) 2001-12-18 2001-12-18 Vaccine
PCT/EP2002/014476 WO2003051392A2 (en) 2001-12-18 2002-12-18 Streptococcus pneumoniae vaccine

Publications (1)

Publication Number Publication Date
NO20043018L true NO20043018L (no) 2004-07-15

Family

ID=9927830

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043018A NO20043018L (no) 2001-12-18 2004-07-15 Streptococcus pneumoniae vaksine

Country Status (19)

Country Link
US (1) US20050214329A1 (no)
EP (1) EP1463519A2 (no)
JP (1) JP2005516932A (no)
KR (1) KR20040074091A (no)
CN (1) CN1635904A (no)
AU (1) AU2002361007A1 (no)
BR (1) BR0215089A (no)
CA (1) CA2470645A1 (no)
CO (1) CO5590937A2 (no)
GB (1) GB0130215D0 (no)
HU (1) HUP0402471A3 (no)
IL (1) IL162383A0 (no)
IS (1) IS7297A (no)
MX (1) MXPA04006073A (no)
NO (1) NO20043018L (no)
PL (1) PL370804A1 (no)
RU (1) RU2004117775A (no)
WO (1) WO2003051392A2 (no)
ZA (1) ZA200404803B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763244B1 (fr) 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc Composition vaccinale multivalente a porteur mixte
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
CA2604363C (en) * 2005-04-08 2015-06-16 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
AU2011253684B8 (en) * 2005-04-08 2013-07-11 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
PL1973564T3 (pl) 2005-12-22 2017-04-28 Glaxosmithkline Biologicals S.A. Szczepionki zawierające koniugaty polisacharydu otoczkowego streptococcus pneumoniae
AU2012216698B2 (en) * 2005-12-22 2014-03-06 Glaxosmithkline Biologicals Sa Pneumococcal polysaccharide conjugate vaccine
WO2007127668A2 (en) * 2006-04-26 2007-11-08 Wyeth Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
AU2007285775B2 (en) * 2006-08-17 2011-03-03 Sanofi Pasteur Ltd. Immunogenic PcpA polypeptides and uses thereof
CN1971275B (zh) * 2006-12-06 2012-07-04 云南沃森生物技术股份有限公司 肺炎链球菌6b型、18c型、19f型、23f型多糖结合物中游离多糖含量的测定方法
BRPI0810778A2 (pt) * 2007-05-02 2011-09-13 Glaxosmithkline Biolog Sa kit, vacina combinada, e, métodos de diminuição da interferência de vizinhança de crm sobre um antìgeno sensìvel em um esquema de imunização primária de uma vacina, e de diminuição da interferência de vizinhança sobre um antìgeno sensìvel, e, uso de conjugados de sacarìdeo
SI2167121T1 (sl) * 2007-06-26 2015-12-31 Glaxosmithkline Biologicals S.A. Cepivo, ki obsega kapsularne polisaharidne konjugate Streptococcusa pneumoniae
US20160228500A9 (en) * 2007-07-23 2016-08-11 Martina Ochs Immunogenic Polypeptides and Monoclonal Antibodies
BRPI0814127A2 (pt) * 2007-07-23 2015-02-03 Sanofi Pasteur Ltd Polipeptídeos imunegênicos e anticorpos monoclonais
GB201003924D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
KR20140009281A (ko) 2010-12-03 2014-01-22 사노피 파스퇴르 리미티드 / 사노피 파스퇴르 리미떼 스트렙토코커스 뉴모니애에 대한 면역화를 위한 조성물
DK2809349T3 (da) * 2012-01-30 2019-02-18 Serum Institute Of India Pvt Ltd Immunogen sammensætning
JP2015534964A (ja) * 2012-10-17 2015-12-07 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
US20140105927A1 (en) * 2012-10-17 2014-04-17 Glaxosmithkline Biologicals S.A. Immunogenic composition
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
CN106109486A (zh) * 2015-07-06 2016-11-16 北京科兴中维生物技术有限公司 一种组合物及其制备方法与应用
WO2018144799A1 (en) 2017-02-03 2018-08-09 SCHADECK, Eva, Barbara Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
MX2019014829A (es) 2017-06-10 2020-08-17 Inventprise Llc Vacunas de conjugado multivalente con polisacáridos de conjugado bivalente o multivalente que proporcionan inmunogenicidad y avidez mejoradas.
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
US12257295B2 (en) 2017-10-04 2025-03-25 Pogona, LLC Saccharide-polypeptide conjugate compositions and methods of use thereof
TWI725359B (zh) 2017-12-06 2021-04-21 美商默沙東藥廠 包含肺炎鏈球菌多醣-蛋白結合物之組合物及其使用方法
KR20230008923A (ko) 2018-02-05 2023-01-16 사노피 파스퇴르 인코포레이티드 다가 폐렴구균성 다당류-단백질 접합체 조성물
JP2021522213A (ja) * 2018-04-18 2021-08-30 エスケー バイオサイエンス カンパニー リミテッド ストレプトコッカス・ニューモニエ莢膜多糖類及びその免疫原性接合体
WO2022035816A1 (en) 2020-08-10 2022-02-17 Inventprise, Llc Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f
KR20220102871A (ko) * 2021-01-14 2022-07-21 (주)셀트리온 다가 폐렴구균 다당류-단백질 접합체를 포함하는 면역원성 조성물
CN118702827B (zh) 2024-08-27 2025-03-07 南京澄实生物医药科技有限公司 一种预防肺炎链球菌感染的融合蛋白及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811102A (en) * 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
FR2763244B1 (fr) * 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc Composition vaccinale multivalente a porteur mixte
ES2275499T3 (es) * 1999-03-19 2007-06-16 Glaxosmithkline Biologicals S.A. Vacuna contra streptococcus pneumoniae.

Also Published As

Publication number Publication date
JP2005516932A (ja) 2005-06-09
HUP0402471A3 (en) 2005-04-28
EP1463519A2 (en) 2004-10-06
HUP0402471A2 (hu) 2005-03-29
AU2002361007A1 (en) 2003-06-30
IL162383A0 (en) 2005-11-20
PL370804A1 (en) 2005-05-30
CN1635904A (zh) 2005-07-06
CA2470645A1 (en) 2003-06-26
WO2003051392A2 (en) 2003-06-26
RU2004117775A (ru) 2005-04-20
CO5590937A2 (es) 2005-12-30
BR0215089A (pt) 2004-11-16
GB0130215D0 (en) 2002-02-06
ZA200404803B (en) 2005-08-29
IS7297A (is) 2004-06-03
KR20040074091A (ko) 2004-08-21
WO2003051392A3 (en) 2003-11-13
US20050214329A1 (en) 2005-09-29
MXPA04006073A (es) 2005-03-31

Similar Documents

Publication Publication Date Title
NO20043018L (no) Streptococcus pneumoniae vaksine
ATE346608T1 (de) Impstoff gegen streptococcus pneumoniae
NO20026121D0 (no) Streptokokkantigener
GB0107658D0 (en) Streptococcus pneumoniae
NO20031483D0 (no) Vaksine
PL363005A1 (pl) Szczepionki
DK1390066T3 (da) Vaccinesammensætning
AU2002351623A8 (en) Streptococcus antigens
NO20024172D0 (no) Vaksine
EP1302761A4 (en) PYROMETER
DK1427444T3 (da) West-nil-vaccine
DE60208379D1 (de) Haltevorrichtung
DK1303521T3 (da) Tetrahydro-heterocycloazepinyl-pyrimidinderivater
EP1490104A4 (en) PROTEIN-BASED STREPTOCOCCUS PNEUMONIAE VACCINES
NO20033882L (no) Vaksine
DK1265633T3 (da) Vaccineadjuvans
DE10293048T1 (de) Neuer Impfstoff
DE60221403D1 (de) Doppelstrom - verdichter
DE60042591D1 (de) Thermoelektrisches system
EE200300480A (et) Pregabaliini-laktoosi konjugaadid
ATA17102002A (de) Distanzhalter
ES1049528Y (es) Almohada hidroneumatica
ITPO20010001U1 (it) Guanciale orozio
UA6118S (uk) Подушка
ITBO20010095V0 (it) Dispositivo distanziatore

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application